Testing antibiotic add-on therapy for lung fibrosis flare-ups

This trial is testing whether azithromycin, an antibiotic, can help when added to standard emergency treatment for people experiencing a sudden flare-up of idiopathic pulmonary fibrosis (a serious lung condition where lung tissue becomes scarred). Researchers want to see if this medication, given alongside standard care, can improve outcomes when the disease suddenly gets worse. The trial will also compare this approach with other treatment options.

Acute flare-ups of pulmonary fibrosis can be very serious and unpredictable. Current standard treatments help, but doctors are looking for better ways to manage these sudden worsening episodes, and this medication may offer a new option to reduce inflammation during these critical times.